Sichuan Goldstone Asia Pharmaceutical Inc. 300434.SZ Stock
Sichuan Goldstone Asia Pharmaceutical Inc. Price Chart
Sichuan Goldstone Asia Pharmaceutical Inc. 300434.SZ Financial and Trading Overview
Contents
- Sichuan Goldstone Asia Pharmaceutical Inc. Price Chart
- Sichuan Goldstone Asia Pharmaceutical Inc. 300434.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Sichuan Goldstone Asia Pharmaceutical Inc.
- Q&A For Sichuan Goldstone Asia Pharmaceutical Inc. Stock
Sichuan Goldstone Asia Pharmaceutical Inc. stock price | 8.43 CNY |
Previous Close | 14.11 CNY |
Open | 14.18 CNY |
Bid | 14.13 CNY x 0 |
Ask | 14.14 CNY x 0 |
Day's Range | 14.1 - 14.39 CNY |
52 Week Range | 7.4 - 23.16 CNY |
Volume | 8.04M CNY |
Avg. Volume | 19.3M CNY |
Market Cap | 5.68B CNY |
Beta (5Y Monthly) | 0.221917 |
PE Ratio (TTM) | 19.90141 |
EPS (TTM) | 0.62 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | August 11, 2020 |
1y Target Est | N/A |
300434.SZ Valuation Measures
Enterprise Value | 5.27B CNY |
Trailing P/E | 19.90141 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.2130175 |
Price/Book (mrq) | 2.3479562 |
Enterprise Value/Revenue | 3.91 |
Enterprise Value/EBITDA | 11.068 |
Trading Information
Sichuan Goldstone Asia Pharmaceutical Inc. Stock Price History
Beta (5Y Monthly) | 0.221917 |
52-Week Change | 60.34% |
S&P500 52-Week Change | 20.43% |
52 Week High | 23.16 CNY |
52 Week Low | 7.4 CNY |
50-Day Moving Average | 13.87 CNY |
200-Day Moving Average | 11.99 CNY |
300434.SZ Share Statistics
Avg. Volume (3 month) | 19.3M CNY |
Avg. Daily Volume (10-Days) | 16.19M CNY |
Shares Outstanding | 401.74M |
Float | 160.07M |
Short Ratio | N/A |
% Held by Insiders | 63.00% |
% Held by Institutions | 2.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1.8:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 21.94% |
Operating Margin (ttm) | 28.56% |
Gross Margin | 63.66% |
EBITDA Margin | 35.32% |
Management Effectiveness
Return on Assets (ttm) | 8.46% |
Return on Equity (ttm) | 12.50% |
Income Statement
Revenue (ttm) | 1.35B CNY |
Revenue Per Share (ttm) | 3.31 CNY |
Quarterly Revenue Growth (yoy) | 33.30% |
Gross Profit (ttm) | 762.11M CNY |
EBITDA | 476.03M CNY |
Net Income Avi to Common (ttm) | 295.67M CNY |
Diluted EPS (ttm) | 0.71 |
Quarterly Earnings Growth (yoy) | 115.50% |
Balance Sheet
Total Cash (mrq) | 445.9M CNY |
Total Cash Per Share (mrq) | 1.11 CNY |
Total Debt (mrq) | 17.7M CNY |
Total Debt/Equity (mrq) | 0.72 CNY |
Current Ratio (mrq) | 2.408 |
Book Value Per Share (mrq) | 6.018 |
Cash Flow Statement
Operating Cash Flow (ttm) | 250M CNY |
Levered Free Cash Flow (ttm) | 179.8M CNY |
Profile of Sichuan Goldstone Asia Pharmaceutical Inc.
Country | China |
State | N/A |
City | Chengdu |
Address | A1, Dadi New Guanghua Plaza |
ZIP | 610072 |
Phone | 86 28 8708 6857 |
Website | https://www.goldstone-group.com |
Industry | Industrial Distribution |
Sector(s) | Industrials |
Full Time Employees | 1878 |
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, manufacture, and sale of medicines and health products in China and internationally. The company offers various pharmaceutical preparations and APIs; Chinese and western pharmaceutical preparations and raw materials; and tablets, capsules, dietary supplements, vitamin products, OTC products, and prescription drugs. It also trades in various pharmaceutical products, such as Chinese herbal medicine materials, Chinese patent medicines, Chinese herbal pieces, chemical raw materials, pharmaceutical preparations, antibiotic preparations, biochemical drugs, dietary supplements, and toxic drugs for medical use, medical devices, etc.; and sells adult drug products under the Quike brand and children's general medicine products under the Mini-Quike brand name. In addition, the company researches, develops, manufactures, and sells plastic composite pipe and vacuum coating machines. Further, it offers reinforced pipe equipment, such as steel reinforced corrugated pipes, reinforced composite polyethylene pipes, fiberglass reinforced RTP pipes, steel reinforced large diameter pipes, steel reinforced corrugated pipe socket and spigot making machines, abrasion resistant industries pipes, extrusion pipe fittings, and perforated steel reinforced polyethylene composite pipes. Additionally, the company provides vacuum coating equipment, including low-emissivity glass coating lines, reflect glass magnetron sputtering coating lines, magnetron sputtering mirror coating production lines, vacuum sputter systems for automotive car mirrors, ITO/TCO glass coating machines, sputtering metallization machines, optical lens coating machines, roll web metallization machines, and air-to-air solar absorption strip sputtering production line; and smart parking equipment. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 2001 and is based in Chengdu, China.
Q&A For Sichuan Goldstone Asia Pharmaceutical Inc. Stock
What is a current 300434.SZ stock price?
Sichuan Goldstone Asia Pharmaceutical Inc. 300434.SZ stock price today per share is 8.43 CNY.
How to purchase Sichuan Goldstone Asia Pharmaceutical Inc. stock?
You can buy 300434.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sichuan Goldstone Asia Pharmaceutical Inc.?
The stock symbol or ticker of Sichuan Goldstone Asia Pharmaceutical Inc. is 300434.SZ.
Which industry does the Sichuan Goldstone Asia Pharmaceutical Inc. company belong to?
The Sichuan Goldstone Asia Pharmaceutical Inc. industry is Industrial Distribution.
How many shares does Sichuan Goldstone Asia Pharmaceutical Inc. have in circulation?
The max supply of Sichuan Goldstone Asia Pharmaceutical Inc. shares is 401.74M.
What is Sichuan Goldstone Asia Pharmaceutical Inc. Price to Earnings Ratio (PE Ratio)?
Sichuan Goldstone Asia Pharmaceutical Inc. PE Ratio is 13.59677500 now.
What was Sichuan Goldstone Asia Pharmaceutical Inc. earnings per share over the trailing 12 months (TTM)?
Sichuan Goldstone Asia Pharmaceutical Inc. EPS is 0.62 CNY over the trailing 12 months.
Which sector does the Sichuan Goldstone Asia Pharmaceutical Inc. company belong to?
The Sichuan Goldstone Asia Pharmaceutical Inc. sector is Industrials.